CARIBOU BIOSCIENCES INC's ticker is and the CUSIP is 142038108. A total of 128 filers reported holding CARIBOU BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,395,239 | +30.4% | 291,891 | +16.0% | 0.00% | +50.0% |
| Q2 2023 | $1,069,594 | -9.8% | 251,669 | +12.7% | 0.00% | -33.3% |
| Q1 2023 | $1,185,389 | -11.2% | 223,237 | +5.0% | 0.00% | 0.0% |
| Q4 2022 | $1,335,448 | -49.7% | 212,651 | -15.5% | 0.00% | -57.1% |
| Q3 2022 | $2,655,000 | +123.7% | 251,630 | +15.1% | 0.01% | +133.3% |
| Q2 2022 | $1,187,000 | -14.5% | 218,665 | +44.7% | 0.00% | +200.0% |
| Q1 2022 | $1,388,000 | -48.6% | 151,165 | -15.5% | 0.00% | -83.3% |
| Q4 2021 | $2,700,000 | – | 178,913 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 674,196 | $10,174,000 | 6.39% |
| 72 Investment Holdings, LLC | 474,067 | $7,154,000 | 6.35% |
| Velan Capital Investment Management LP | 210,695 | $3,179,000 | 2.47% |
| PFM Health Sciences, LP | 4,092,309 | $59,418,000 | 2.02% |
| Monashee Investment Management LLC | 504,377 | $7,611,000 | 1.88% |
| CloudAlpha Capital Management Limited/Hong Kong | 415,000 | $6,262,000 | 1.49% |
| Avidity Partners Management LP | 2,674,067 | $40,352,000 | 0.86% |
| Rokos Capital Management LLP | 570,359 | $8,604,000 | 0.52% |
| Green Alpha Advisors, LLC | 35,592 | $537,000 | 0.36% |
| Tekla Capital Management LLC | 699,377 | $9,875,000 | 0.32% |